| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/8.SUPPL_B.23 |
| P698 | PubMed publication ID | 19802967 |
| P2093 | author name string | A King | |
| K Shannon | |||
| I Phillips | |||
| C Warren | |||
| D Hanslo | |||
| P921 | main subject | cefotaxime | Q417968 |
| ceftazidime | Q808845 | ||
| P304 | page(s) | 23-31 | |
| P577 | publication date | 1981-09-01 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics | |
| P478 | volume | 8 Suppl B |
| Q54687938 | A Comparative Study on Aztreonam, Ceftazidime and Amikacin in the Treatment of Complicated Urinary Tract Infections |
| Q40135061 | Cefotaxime A review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use |
| Q72526504 | Ceftazidime--a new extended-spectrum cephalosporin |
| Q34193382 | Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. |
| Q39732196 | Cephalosporin therapeutics in cystic fibrosis |
| Q39685284 | Cephalosporins in gram-positive infections |
| Q41477969 | Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis |
| Q70246056 | Comparative activity in vitro of ceftazidime and nine other antibacterial agents |
| Q28295653 | Comparative in vitro study of the antimicrobial activity of ceftazidime against clinical isolates |
| Q69516800 | Concentrations of ceftazidime, tobramycin and ampicillin in the cerebrospinal fluid of newborn infants |
| Q54516017 | Development of resistance to beta-lactam antibiotics during therapy of Pseudomonas aeruginosa infections |
| Q40716375 | Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients |
| Q36716623 | Drug treatment of pneumonia in the hospital. What are the choices? |
| Q33475749 | Efficacy of chloramphenicol in the treatment of neonatal and infantile meningitis: a study of 70 cases |
| Q39685324 | In vitro antibacterial effects of cephalosporins. |
| Q38827899 | Modeling intraocular bacterial infections |
| Q34708690 | Moxalactam (Latamoxef) A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use |
| Q70251953 | Pharmacokinetics and tissue concentrations of ceftazidime in burn patients |
| Q50180575 | Pharmacokinetics of ceftazidime in patients with biliary tract disease |
| Q54516014 | Pseudomonas aeruginosa isolates with modified beta-lactamase inducibility: effects on beta-lactam sensitivity |
| Q70246073 | The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates |
| Q70220882 | The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy |
| Q68931319 | [Biological bases for the use of ceftazidime in anti-infection therapy] |
Search more.